Edgewise Therapeutics Inc’s recently made public that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $2.74 million on Dec 30 ’24. In the deal valued at $27.37 per share,100,000 shares were sold. As a result of this transaction, Russell Alan J now holds 14,863 shares worth roughly $0.41 million.
Then, ALAN J RUSSELL bought 100,000 shares, generating $2,874,000 in total proceeds.
Before that, Semigran Marc sold 29,709 shares. Edgewise Therapeutics Inc shares valued at $881,915 were divested by the Chief Development Officer at a price of $29.69 per share. As a result of the transaction, Semigran Marc now holds 6,716 shares, worth roughly $0.19 million.
Evercore ISI initiated its Edgewise Therapeutics Inc [EWTX] rating to an Outperform in a research note published on November 22, 2024; the price target was $45. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early March with a ‘”an Overweight”‘ rating. Truist began covering EWTX with “Buy” recommendation on May 01, 2023. Goldman revised its rating on August 25, 2022. It rated EWTX as “a Sell” which previously was an “a Neutral”.
Price Performance Review of EWTX
On Friday, Edgewise Therapeutics Inc [NASDAQ:EWTX] saw its stock jump 2.55% to $27.72. Over the last five days, the stock has lost -6.54%. Edgewise Therapeutics Inc shares have risen nearly 3.82% since the year began. Nevertheless, the stocks have risen 175.82% over the past one year. While a 52-week high of $38.12 was reached on 01/03/25, a 52-week low of $9.00 was recorded on 01/02/25. SMA at 50 days reached $31.89, while 200 days put it at $22.92.
Levels Of Support And Resistance For EWTX Stock
The 24-hour chart illustrates a support level at 27.09, which if violated will result in even more drops to 26.45. On the upside, there is a resistance level at 28.31. A further resistance level may holdings at 28.89. The Relative Strength Index (RSI) on the 14-day chart is 40.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.64%. Stochastics %K at 12.38% indicates the stock is a buying.
How much short interest is there in Edgewise Therapeutics Inc?
A steep rise in short interest was recorded in Edgewise Therapeutics Inc stocks on 2024-12-13, dropping by -0.75 million shares to a total of 5.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.39 million shares. There was a decline of -13.28%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 13, 2022 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $31 price target.
